Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Medimmune Ventures, Inc.
Relationship:   10% Owner
City:   Gaithersburg
State:   MD
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   6,224,390    

Indirect Shares

  1,917,906      
Direct Value   $30,748,591    

Indirect Value

  $41,273,337      
Total Shares   8,142,296      
Total Value   $72,021,928      


Applied Genetic Technologies Corp
 $571,584 Rocket Pharmaceuticals
 $4,065,386 Astria Therapeutics, Inc
 $14,987,745 G1 Therapeutics Inc
 $11,123,875 Applied Genetic Technologies Corp
 $571,584 Rocket Pharmaceuticals
 $4,065,386 Astria Therapeutics, Inc
 $14,987,745 G1 Therapeutics Inc
 $11,123,875
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Applied Genetic Technologies Corp AGTC 10% Owner 2014-04-01 1,452,196 2014-04-01 0    Premium*  
            Rocket Pharmaceuticals RCKT 10% Owner 2015-02-17 188,912 2015-02-23 1,917,906    Premium*  
            Astria Therapeutics, Inc ATXS 10% Owner 2015-06-30 1,632,652 2015-06-30 0    Premium*  
            G1 Therapeutics Inc GTHX 10% Owner 2017-12-15 2,950,630 2017-05-22 0    Premium*  
* Premium Members only  

Records found :    13         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-12-15 4 S $19.75 $3,950,000 D/D (200,000) 2,950,630 0 -
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-12-01 4 S $19.75 $2,644,644 D/D (133,906) 3,150,630 0 -
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-11-20 4 S $20.01 $4,002,000 D/D (200,000) 3,284,536 0 -
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-05-22 4 B $15.00 $1,125,000 D/D 75,000 3,484,536 2.45 -
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-05-22 4 A $0.00 $0 D/D 3,409,536 3,409,536 0 -
GTHX G1 Therapeutics Inc 10% Owner   –       –       •   2017-05-17 4/A B $15.00 $1,125,000 D/D 75,000 3,409,536 2.45 -
ATXS Astria Therapeutics, Inc 10% Owner   –       –       •   2015-06-30 4 B $12.00 $2,681,268 D/D 223,439 1,632,652 2.45 -
ATXS Astria Therapeutics, Inc 10% Owner   –       –       •   2015-06-30 4 A $0.00 $0 D/D 1,409,213 1,409,213 0 -
RCKT Rocket Pharmaceuticals 10% Owner   –       –       •   2015-02-23 4 B $6.00 $2,500,002 I/I 416,667 1,917,906 1.5 -
RCKT Rocket Pharmaceuticals 10% Owner   –       –       •   2015-02-23 4 A $0.00 $0 I/I 1,312,327 1,501,239 0 -
RCKT Rocket Pharmaceuticals 10% Owner   –       –       •   2015-02-17 3 IO $0.00 $0 D/D 0 188,912 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-04-01 4 B $12.00 $908,820 D/D 75,735 1,452,196 2.45 -
AGTC Applied Genetic Technolog... 10% Owner   –       –       •   2014-04-01 4 A $0.00 $0 D/D 1,376,461 1,376,461 0 -

  13  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed